Homologous recombination deficiency signature (HRDsig+) and the genomic landscape of clinically advanced prostate carcinoma (CAPC).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Chiara Mercinelli, Philippe E. Spiess, Roger Li, Ashish M. Kamat, Petros Grivas, Shilpa Gupta, Neeraj Agarwal, Liang Cheng, Dean Pavlick, Ethan Sokol, Ryon P Graf, Jeffrey S. Ross, Alexa Betzig Schrock, Julia Quintanilha, Gerald Li, Douglas I Lin, Joseph M Jacob, Gennady Bratslavsky, Alina Basnet, Andrea Necchi
Institutions: IRCCS Ospedale San Raffaele, Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, University of Washington, Fred Hutch Cancer Center, Cleveland Clinic, Huntsman Cancer Institute, Indiana University Indianapolis, Foundation Medicine (United States), SUNY Upstate Medical University, Vita-Salute San Raffaele University, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407700107